Remarkably, the tumor formation rates were significantly decelerated in the CDH4-silencing groups compared to the control groups, and there was also a notable reduction in tumor weight observed in the CDH4-knockdown groups (Fig. 3B, C). This evidence concerns the gene CDH4 and neoplasm.